Indian journal of pathology & microbiology · 2025
Light-chain-restricted hematogones are a potential diagnostic pitfall for B-cell lymphoma.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Xiaofeng, Zhang Zhihua, Yang Xinhong
Аннотация
BACKGROUND AND OBJECTIVE: The aim is to differentiate light-chain-restricted hematogones (LCR-HGs) from B-cell lymphoma.
MATERIALS AND METHODS: We identified eight patients who underwent bone marrow (BM) flow cytometry (FLC) diagnosis or evaluation for lymphoma/multiple myeloma.
RESULTS: Among the eight cases, there are two chronic lymphocytic leukemia, one marginal zone lymphoma, one mantle cell lymphoma, one multiple myeloma, one hepar diffuse large B-cell lymphoma, and one monomorphic epitheliotropic intestinal T-cell lymphoma, in whom FLC immunophenotypes of BM-aspirated specimens showed LCR-HGs.
CONCLUSION: Failure to recognize LCR-HGs and diagnostic test interference associated with antibody-based therapies leads to erroneous diagnosis.
MATERIALS AND METHODS: We identified eight patients who underwent bone marrow (BM) flow cytometry (FLC) diagnosis or evaluation for lymphoma/multiple myeloma.
RESULTS: Among the eight cases, there are two chronic lymphocytic leukemia, one marginal zone lymphoma, one mantle cell lymphoma, one multiple myeloma, one hepar diffuse large B-cell lymphoma, and one monomorphic epitheliotropic intestinal T-cell lymphoma, in whom FLC immunophenotypes of BM-aspirated specimens showed LCR-HGs.
CONCLUSION: Failure to recognize LCR-HGs and diagnostic test interference associated with antibody-based therapies leads to erroneous diagnosis.